Epcoritamab,rituximab,cyclophosphamide,doxorubicin,vincristine,prednisone,lenalidomide,bendamustine,cytarabine,dexamethasone,oxaliplatin,carboplatin,gemcitabine,ifosfamide
Genmab,Abbvie
['epcore,nhl,1', 'lenalidomide', 'epcore,nhl,2', 'follicular', 'epcoritamab', 'nhl', 'epcore,nhl,i,(-ii)', 'epcore,fl,1', 'rituximab', 'lymphoma', 'ritux', 'epcore,nhl,3', '$gmab']
$gmab data from phase 1/2 epcore nhl-2 trial of epcoritamab in combination with rituximab-lenalidomide (r2) showed a 98% orr and 87% cmr in patients with relapsed or refractory follicular lymphoma (fl). #eha23 
Investor/trader focused primarily in the biopharma sector. 
Tweets are not investment advice and are not recommendations of any kind.